HAEMOTOLOGY ONCOLOGY

Feb 24, 2020

F. Coussy et al sought to determine the response to PI3K and MAPK pathway inhibitors in patient-derived xenografts of MBCs with targetable alterations. The treatment of metaplastic…

Feb 20, 2020

Patients with relapsed or refractory large B-cell non-Hodgkin lymphoma can be successfully treated and monitored in the outpatient setting with the chimeric antigen receptor T-cell therapy…

Feb 14, 2020

Kaloyannidis P et al compared salvage chemotherapy with brentuximab vedotin in terms of efficacy to treat relapsed refractory classical Hodgkin lymphoma patients post autologous…

Feb 11, 2020

MiR-612 has been proven to suppress EMT, tumor metastasis and stemness of hepatocellular carcinoma, but its biological roles on HCC progression are far from elucidated. Yang Liu…

Feb 10, 2020

In order to reduce transplant-related morbidity and mortality among older patients with blood cancer, a new study suggested evaluation by a multidisciplinary team clinic before…

Feb 06, 2020

As has been discovered for several other types of tumors, there is increasing evidence to suggest the importance of myeloid-derived suppressor cells in the progression and…